PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33237350-8	2020	Western blot, quantitative RT-PCR and next-generation sequencing transcriptomic analyses were performed to assess the expression levels of amino acid transporters (including LAT1 and ASCT2, which have been implicated for Fluciclovine uptake).	fluciclovine F-18	221-233	solute carrier family 7 member 5	Homo sapiens	174-178	
33237350-12	2020	We studied the expression of amino acid transporters (AATs) for 18F-Fluciclovine, namely LAT1 (SLC7A5 and SLC3A2) and ASCT2 (SLC1A5).	fluciclovine F-18	64-80	solute carrier family 7 member 5	Homo sapiens	95-101	
31283597-2	2019	As an amino acid-based radiotracer transported by LAT-1 and ASCT-2 transporters, fluciclovine exploits the up-regulation of amino acid transporters in malignant cells.	fluciclovine F-18	81-93	solute carrier family 7 member 5	Homo sapiens	50-55	
32956127-3	2021	18F-fluciclovine uptake is mediated by amino acid transporters, primarily alanine-serine-cysteine transporter 2 and l-type amino acid transporter 1, previously demonstrated to be expressed on thymic carcinomas.	fluciclovine F-18	4-16	solute carrier family 7 member 5	Homo sapiens	116-147	
32395349-5	2020	First, 18F-fluciclovine is a radiolabeled synthetic amino acid targeting the amino acid transporters ASCT2 and LAT1, which are ubiquitous throughout the body, but overexpressed in prostate cancer.	fluciclovine F-18	7-23	solute carrier family 7 member 5	Homo sapiens	111-115	
31152256-0	2019	Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.	fluciclovine F-18	71-87	solute carrier family 7 member 5	Homo sapiens	164-195	
31152256-0	2019	Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.	fluciclovine F-18	71-87	solute carrier family 7 member 5	Homo sapiens	197-201	
31152256-1	2019	PURPOSE: To evaluate the expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter1 (LAT1) in prostate cancer (PCa) and their impact on uptake of 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) which is approved for the detection of recurrent PCa.	fluciclovine F-18	233-249	solute carrier family 7 member 5	Homo sapiens	121-125	
31152256-12	2019	The uptake of 18F-fluciclovine correlated significantly with LAT1 expression (rho = 0.39, p = 0.01, for SUVmax at 2 min and rho = 0.39, p = 0.01 for VT).	fluciclovine F-18	14-30	solute carrier family 7 member 5	Homo sapiens	61-65	
31152256-14	2019	CONCLUSIONS: Our findings suggest that LAT1 is moderately associated with the transport of 18F-fluciclovine in local PCa not exposed to hormonal therapy.	fluciclovine F-18	91-107	solute carrier family 7 member 5	Homo sapiens	39-43